×
About 1,270 results

ALLMedicine™ Malignant Hyperthermia Center

Research & Reviews  438 results

Malignant Hyperthermia.
https://doi.org/10.1002/aorn.13802
AORN Journal;

Sep 28th, 2022 - Malignant Hyperthermia.|2022||

Intravenous dantrolene in hypermetabolic syndromes: a survey of the U.S. Veterans Healt...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484236
BMC Anesthesiology; Caroff SN, Roberts CB et. al.

Sep 20th, 2022 - Intravenous dantrolene is often prescribed for hypermetabolic syndromes other than the approved indication of malignant hyperthermia (MH). To clarify the extent of and indications for dantrolene use in conditions other than MH, we sought to docume...

Comparison of Postoperative QoR-15 Scores Between Desflurane and Remimazolam in Lumbar Fusion Surgery
https://clinicaltrials.gov/ct2/show/NCT04983966

Sep 16th, 2022 - The purpose of the study is to compare the quality of recovery (QoR)-15 scores according to the use of maintenance anesthetics in the lumbar fusion surgery. Total intravenous anesthesia (TIVA) have been known to help reducing risks of postoperativ...

STAC3 related congenital myopathy: A case series of seven Comorian patients.
https://doi.org/10.1016/j.ejmg.2022.104598
European Journal of Medical Genetics; Gromand M, Gueguen P et. al.

Aug 28th, 2022 - The Bailey-Bloch congenital myopathy, also known as Native American myopathy (NAM), is an autosomal recessive congenital myopathy first reported in the Lumbee tribe people settled in North Carolina (USA), and characterized by congenital weakness a...

Neuroleptic Malignant Syndrome Medication
http://emedicine.medscape.com/article/816018-medication

Aug 8th, 2022 - Medication Summary Specific drug therapies, such as dantrolene, amantadine, and bromocriptine, have an uncertain role in the treatment of neuroleptic malignant syndrome. Recommendations for the use of these drugs are from noncontrolled prospective...

see more →

Guidelines  4 results

Consensus guidelines on perioperative management of malignant hyperthermia suspected or...
https://doi.org/10.1016/j.bja.2020.09.029
British Journal of Anaesthesia; Rüffert H, Bastian B et. al.

Nov 3rd, 2020 - Malignant hyperthermia is a potentially fatal condition, in which genetically predisposed individuals develop a hypermetabolic reaction to potent inhalation anaesthetics or succinylcholine. Because of the rarity of malignant hyperthermia and ethic...

Availability of dantrolene for the management of malignant hyperthermia crises: Europea...
https://doi.org/10.1016/j.bja.2020.04.089
British Journal of Anaesthesia; Glahn KPE, Bendixen D et. al.

Jun 28th, 2020 - Faced with a malignant hyperthermia crisis, the immediate access to sufficient dantrolene is essential to achieve the best possible outcome for the patient. However, malignant hyperthermia crises are rare, and there may be administrative pressures...

Malignant Hyperthermia-Susceptible Adult Patient and Ambulatory Surgery Center: Society...
https://doi.org/10.1213/ANE.0000000000004257
Anesthesia and Analgesia; Urman RD, Rajan N et. al.

Jun 6th, 2019 - This document represents a joint effort of the Society for Ambulatory Anesthesia (SAMBA) and the Ambulatory Surgical Care Committee of the American Society of Anesthesiologists (ASA) concerning the safe anesthetic care of adult malignant hyperther...

Special article: Creation of a guide for the transfer of care of the malignant hyperthe...
https://doi.org/10.1213/ANE.0b013e3182373b4a
Anesthesia and Analgesia; Larach MG, Dirksen SJ et. al.

Nov 5th, 2011 - Volatile anesthetics and/or succinylcholine may trigger a potentially lethal malignant hyperthermia (MH) event requiring critical care crisis management. If the MH triggering anesthetic is given in an ambulatory surgical center (ASC), then the pat...

see more →

Drugs  14 results see all →

Clinicaltrials.gov  34 results

Comparison of Postoperative QoR-15 Scores Between Desflurane and Remimazolam in Lumbar Fusion Surgery
https://clinicaltrials.gov/ct2/show/NCT04983966

Sep 16th, 2022 - The purpose of the study is to compare the quality of recovery (QoR)-15 scores according to the use of maintenance anesthetics in the lumbar fusion surgery. Total intravenous anesthesia (TIVA) have been known to help reducing risks of postoperativ...

Screening of Malignant Hyperthermia Susceptible Individuals
https://clinicaltrials.gov/ct2/show/NCT05402839

Jun 2nd, 2022 - This study intends to target patients who underwent surgery under general anesthesia during the study period and developed malignant hyperthermia during or after surgery. Therefore, the total sample size was estimated to be about 50 people based o...

Malignant Hyperthermia in Czech Republic: Description of the Biggest Slavonic Group of Patients Investigated for Risk of Malignant Hyperthermia
https://clinicaltrials.gov/ct2/show/NCT05036148

Apr 15th, 2022 - We evaluated every referral to the MH centre since 2002 then. IVCT results, clinical data, personal and family history and molecular genetic data, have been recorded in an electronic medical record. Potential MHS patients, probands, were investiga...

Comparison of Postoperative QoR-15 Scores Between Sevoflurane and Remimazolam
https://clinicaltrials.gov/ct2/show/NCT05019222

Mar 31st, 2022 - The purpose of the study is to compare the quality of recovery (QoR)-15 scores according to the use of maintenance anesthetics in the cervical spine surgery. Total intravenous anesthesia (TIVA) have been known to help reducing risks of postoperati...

A Case Control Study of Patients With Diagnosis of Malignant Hyperthermia
https://clinicaltrials.gov/ct2/show/NCT02561598

Mar 21st, 2022 - The current study will use the combination of electronic medical records and genomic information in samples of persons who have exhibited signs of Malignant Hyperthermia (MH) or have family history or high risk of MH to see if risk factors can be ...

see more →

News  15 results

Symptoms Mimicking Those of Hypokalemic Periodic Paralysis Induced by Soluble Barium Poisoning
https://www.mdedge.com/fedprac/article/141649/hospital-medicine/symptoms-mimicking-those-hypokalemic-periodic-paralysis
COL (Ret) Terrence J. O’Neil, MD, FASN, USAFMC, Badar Siddiqui

Jul 17th, 2017 - Hypokalemic periodic paralysis (HPP) is a relatively common and potentially life-threating condition that can be either sporadic or recurring and has both inherited and acquired causes. 1 Familial HPP, on the other hand, is a rare condition (1:100.

Coronavirus (COVID-19) Update: Daily Roundup May 26, 2020
http://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-daily-roundup-may-26-2020

For Immediate Release: May 26, 2020 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: The FDA issued an Emergency Use Authorization (EUA) in response to conce...

Coronavirus (COVID-19) Update: December 22, 2020
http://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-december-22-2020

For Immediate Release: December 22, 2020 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: The FDA has posted translations of the Moderna COVID-19 Vaccine fac...

Coronavirus (COVID-19) Update: Daily Roundup June 17, 2020
http://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-daily-roundup-june-17-2020

For Immediate Release: June 17, 2020 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: On June 16, 2020, the FDA approved an abbreviated new drug application ...

Coronavirus (COVID-19) Update: Daily Roundup May 19, 2020
http://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-daily-roundup-may-19-2020

For Immediate Release: May 19, 2020 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: Today, the FDA approved succinylcholine chloride injection USP 200 mg/10...

see more →

Patient Education  3 results see all →